streptococci

Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) 是一种有口服活性的抗生素。它可抑制链球菌，艰难梭菌和金黄色葡萄球菌的生长，可研究中耳炎，鼻窦炎，咽炎和扁桃体炎。

Antibacterial compound 2 是一种有效的抗菌剂，对许多人类兽医病原体有效，对多重耐药葡萄球菌、肠球菌和链球菌，以及厌氧菌有抑制作用。

Mupirocin (BRL-4910A) 是从Pseudomonas fluorescens 中分离得到的一种有口服活性的抗生素。它可逆地抑制异亮氨酸转移RNA，并抑制细菌蛋白和RNA 的合成起抗菌作用。

Mupirocin calcium hydrate 是从Pseudomonas fluorescens 中分离得到的，一种有口服活性的抗生素。它可逆地抑制异亮氨酸转移RNA，并抑制细菌蛋白和RNA 的合成起到抗菌作用。

Sulfazamet 是一种磺胺类衍生物，具有针对(Streptococci sepsis)的抗菌活性。

LB 11058 是一种新型的注射用头孢菌素，含有 C-3 吡啶基取代的乙烯基硫化物及 C-7 的2-氨基-5-氯-1,3-噻唑基团。该化合物对肺炎链球菌具有极高的活性，并对β-溶血性链球菌也展示出了相似的高效作用。LB 11058 对S. aureus的抑制模式类似，所有分离株均在该模式下被抑制。

BB-83698 is a peptide deformylase inhibitor with potent antimicrobial against streptococci and Moraxella catarrhalis strains.

Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.

Isepamicin (Sch 21420) is a potent aminoglycoside antibacterial compound with enhanced efficacy against strains harboring type I 6'-acetyltransferase. Its antibacterial spectrum encompasses Enterobacteriaceae and staphylococci, while exhibiting resistance against anaerobes, Neisseriaceae, and streptococci. Moreover, Isepamicin displays a robust concentration-dependent bactericidal effect, a prolonged post-antibiotic effect lasting several hours, and is capable of inducing adaptive resistance.

Omadacycline, also known as PTK 0796 and Amadacyclin, is a novel first-in-class aminomethylcycline with potent activity against important skin and pneumonia pathogens, including community-acquired methicillin-resistant Staphylococcus aureus (MRSA), β-hemolytic streptococci, penicillin-resistant Streptococcus pneumoniae, Haemophilus influenzae, and Legionella. Omadacycline is active against strains expressing the two main forms of tetracycline resistance (efflux and ribosomal protection). The primary effect of omadacycline is on bacterial protein synthesis, inhibiting protein synthesis with a potency greater than that of tetracycline. The binding site for omadacycline is similar to that for tetracycline.

Ceftobiprole medocaril (BAL5788) sodium 是 Ceftobiprole 的胃肠外前药。Ceftobiprole 是一种非肠道吡咯烷酮头孢菌素。Ceftobiprole 是一种广谱头孢菌素，对甲氧西林 (MRSA) 和耐万古霉素葡萄球菌 (VRSA) 和耐青霉素链球菌具有高水平的体外活性。Ceftobiprole 也抑制革兰氏阳性和革兰氏阴性病原体。

Penicillin V (Phenoxymethylpenicillin) 是一种具口服活性的有效抗生素，对链球菌、艰难梭菌以及金黄色葡萄球菌展现出良好的抗菌效果。此外，Penicillin V 在耳炎、鼻窦炎、咽炎及扁桃体炎方面的治疗潜力[4]，亦在研究之中。

Nemonoxacin (TG-873870) 是一种可口服的非氟化喹诺酮类抗生素，具有广谱的抗菌活性，抑制葡萄球菌、链球菌和肠球菌、淋病奈瑟菌和流感嗜血杆菌均。Nemonoxacin 可用于研究细菌感染和社区获得性肺炎。

Tryglysin A是抗菌肽，具有抑制其他链球菌生长的作用。

Tryglysin B 是一种具有抗菌活性的多肽，能特异性抑制其他链球菌的生长。

Ticarcillin monosodium 是一种半合成广谱羧基青霉素类抗菌剂，对革兰氏阳性球菌（包括链球菌和葡萄球菌）和大多数革兰氏阴性生物（包括绿脓杆菌）都有活性。Ticarcillin monosodium 可用于研究下呼吸道感染、皮肤和皮肤结构感染、尿路感染和腹腔内感染。

Sodium hippurate (N-Benzoylglycine sodium) 可用于细菌培养，例如作用于乙型溶血性链球菌中的B类链球菌，能够将马尿酸钠水解成苯甲酸。

Ethyl Violet Aziode Broth是用于链球菌增菌培养的专用培养基。配置1升培养基的成分为35.8 g Ethyl Violet Aziode Broth。